LIFEVANTAGE CORP Class of Warrant or Right, Outstanding
LIFEVANTAGE CORP (LFVN) had Class of Warrant or Right, Outstanding of 0 shares as of 2019-06-30, per its 10-K filed 2019-08-14.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2019-08-14
- 2019-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2018-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2017-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2019-06-30 | 0.00 shares 10-K · filed 2019-08-14 |
| 2018-06-30 | 0.00 shares 10-K · filed 2018-08-15 |
| 2017-06-30 | 0.00 shares 10-K · filed 2017-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |